Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Growth Hormone Research Society perspective on biomarkers of GH action in children and adults.

Johannsson G, Bidlingmaier M, Biller BMK, Boguszewski M, Casanueva FF, Chanson P, Clayton PE, Choong CS, Clemmons D, Dattani M, Frystyk J, Ho K, Hoffman AR, Horikawa R, Juul A, Kopchick JJ, Luo X, Neggers S, Netchine I, Olsson DS, Radovick S, Rosenfeld R, Ross RJ, Schilbach K, Solberg P, Strasburger C, Trainer P, Yuen KCJ, Wickstrom K, Jorgensen JOL; Growth Hormone Research Society.

Endocr Connect. 2018 Mar;7(3):R126-R134. doi: 10.1530/EC-18-0047. Epub 2018 Feb 26. Review.

2.

Long-term response to growth hormone therapy in a patient with short stature caused by a novel heterozygous mutation in NPR2.

Vasques GA, Hisado-Oliva A, Funari MF, Lerario AM, Quedas EP, Solberg P, Heath KE, Jorge AA.

J Pediatr Endocrinol Metab. 2017 Jan 1;30(1):111-116. doi: 10.1515/jpem-2016-0280.

PMID:
27941173
3.

Food and levothyroxine administration in infants and children.

Zeitler P, Solberg P; Pharmacy and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society.

J Pediatr. 2010 Jul;157(1):13-14.e1. doi: 10.1016/j.jpeds.2010.05.025. No abstract available.

PMID:
20547262
4.

Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development.

Shulman DI, Francis GL, Palmert MR, Eugster EA; Lawson Wilkins Pediatric Endocrine Society Drug and Therapeutics Committee.

Pediatrics. 2008 Apr;121(4):e975-83. doi: 10.1542/peds.2007-2081. Review.

PMID:
18381525

Supplemental Content

Loading ...
Support Center